5 March 2015Americas

Myozyme patents invalidated in first biopharma IPR rulings

The US Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) has handed down what are thought to be the first written decisions in inter partes review proceedings that concern the biopharmaceutical industry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk